Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
26.10
-0.67 (-2.50%)
At close: Apr 18, 2024, 4:00 PM
25.51
-0.59 (-2.26%)
After-hours: Apr 18, 2024, 7:20 PM EDT

Pacira BioSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Net Income
41.9615.9141.98145.52-11.02-0.47-42.61-37.951.86-13.72
Upgrade
Depreciation & Amortization
75.5791.528.5519.9119.5813.1713.8312.9211.4810.04
Upgrade
Share-Based Compensation
47.948.0942.2539.9233.6531.7331.631.2533.3724.82
Upgrade
Other Operating Activities
-10.78-10.2312.94-128.3228.314.4514.9627.24-18.685.42
Upgrade
Operating Cash Flow
154.65145.27125.7277.0370.5248.8717.7933.4528.0226.56
Upgrade
Operating Cash Flow Growth
6.45%15.56%63.20%9.23%44.30%174.78%-46.84%19.39%5.48%-
Upgrade
Capital Expenditures
-15.16-30.08-45.87-37.8-10.16-14.51-19.27-24.71-40.3-22.98
Upgrade
Acquisitions
0-32-424.040-117.69-6.84-8.46-15.86-7.12-13.43
Upgrade
Change in Investments
92.7-163.11449.12-239.81-0.6441.93-196.04-21.1928.16-84.02
Upgrade
Investing Cash Flow
77.54-225.19-20.79-277.61-128.4920.58-223.77-61.75-19.26-120.43
Upgrade
Share Issuance / Repurchase
4.7527.3426.66102.4710.878.958.647.2712.17118.88
Upgrade
Debt Issued / Paid
-187.68-428.87359.2125.43-0.340215.81-0-1.470
Upgrade
Other Financing Activities
-0.11--5.17-5.59-6.86--0.29---
Upgrade
Financing Cash Flow
-183.03-401.53380.69222.33.678.95224.167.2610.7118.88
Upgrade
Net Cash Flow
49.16-481.44485.6221.73-54.378.418.18-21.0419.4625.01
Upgrade
Free Cash Flow
139.49115.279.8539.2360.3634.36-1.488.74-12.273.58
Upgrade
Free Cash Flow Growth
21.09%44.27%103.54%-35.01%75.69%-----
Upgrade
Free Cash Flow Margin
20.67%17.28%14.75%9.13%14.34%10.19%-0.52%3.16%-4.93%1.81%
Upgrade
Free Cash Flow Per Share
3.022.531.800.921.450.84-0.040.23-0.340.10
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).